Vaspin treatment and the adipocyte-specific overexpression of vaspin ameliorate HFD-induced obesity, liver steatosis, and insulin resistance (250, 260, 261), suggesting that the elevation of vaspin levels could be a compensatory mechanism in obesity. The gene discussed is SERPINA12; the disease is Hepatic steatosis.